INDICATIONS:
- Hypertension: Treatment of hypertension in children and adolescents aged 6 to 18 years.
- Recent myocardial infarction: Treatment of symptomatic heart failure in clinically stable adult patients or asymptomatic left ventricular systolic dysfunction following a recent myocardial infarction (12 hours – 10 days).
- Heart failure: Treatment of symptomatic heart failure in adults who cannot tolerate ACE inhibitors or beta-blockers as add-on therapy to ACE inhibitors when mineralocorticoid receptor antagonists cannot be used.
CONTRAINDICATIONS:
Hypersensitivity to valsartan or to any of the excipients.
Severe hepatic impairment, cirrhosis and cholestasis.
Second and third trimesters of pregnancy.
Concomitant use of valsartan with aliskiren-containing products is contraindicated in patients with diabetes or renal impairment (GFR < 60 ml/min/1.73 m2)
DOSAGE:
The drug is administered orally. Absorption is not affected by food.
Choose another valsartan-containing product when a dose < 160 mg is required.
